First automated non-invasive neuromotor screening detects patterns of variability in newborns the human eye and brain are unable to process; Studies underway with Early Detection and Intervention Network of top U.S. neonatal intensive care
SOUTH BEND, In., March 4, 2021 – Enlighten Mobility, a medical device company focused on early intervention solutions to advance development and recovery from loss of mobility announced today an exclusive license agreement with Nationwide Children’s Hospital to develop the GMat Neuromotor Screening tool.
As the first automated non-invasive neuromotor screening for newborns, the GMat serves as an objective indicator for further evaluation by using artificial intelligence to detect patterns of variability the human eye and brain are unable to process.
Studies utilizing the GMat on newborns are currently underway with the Early Detection and Intervention network of top U.S. neonatal intensive care units. Designed by a team of Nationwide Children’s researchers, the GMat accelerates the path to earlier timing and targeting of diagnosis to mitigate loss of vital development opportunities for all children.
“Our license agreement with Nationwide Children’s advances our mission and commitment to early intervention for all individuals,” said Marissa Koscielski, founder of Enlighten Mobility. “Combining Nationwide Children’s technology with the Enlighten Mobility portfolio provides us the opportunity to have accessible neuromotor screening on day one and optimize development and recovery throughout life.”
About Enlighten Mobility
Enlighten Mobility is a medical device company dedicated to empowering individuals with early intervention solutions that advance development and recovery. The company harnesses data for neuromotor abnormalities at every stage of life. Working alongside patients, caregivers and clinicians, Enlighten Mobility drives innovation for technologies that optimize mobility care pathways. Through a collaboration with Nationwide Children’s Hospital, Enlighten Mobility is developing the first automated non-invasive neuromotor screening for newborns, the GMat, currently in studies with the Early Detection and Intervention Network of top U.S. neonatal intensive care units. Studies for the company’s patented independent walking device for lower limb amputees, the Enlight Gait Trainer, continue with The Ohio State University Wexner Medical Center. The GMat and Enlight Gait Trainer lead a robust product pipeline that includes neuromodulation integration for stroke and neurological trauma, motion analysis, biofeedback augmented reality and at-home endurance training to support telehealth. South Bend, In.-based Enlighten Mobility was founded in 2017 by Marissa Koscielski after she experienced firsthand the lack of effective solutions for her own recovery from temporary unilateral immobility and set out to challenge the status quo of mobility care, which remains the company’s mission today. For more information, visit EnlightenMobility.com.
About Nationwide Children’s Hospital
Named to the Top 10 Honor Roll on U.S. News & World Report’s 2020-21 list of “Best Children’s Hospitals,” Nationwide Children’s Hospital is one of America’s largest not-for-profit freestanding pediatric health care systems providing wellness, preventive, diagnostic, treatment and rehabilitative care for infants, children and adolescents, as well as adult patients with congenital disease. Nationwide Children’s has a staff of more than 13,000 providing state-of-the-art pediatric care during more than 1.6 million patient visits annually. As home to the Department of Pediatrics of The Ohio State University College of Medicine, Nationwide Children’s physicians train the next generation of pediatricians and pediatric specialists. The Abigail Wexner Research Institute at Nationwide Children’s Hospital is one of the Top 10 National Institutes of Health-funded freestanding pediatric research facilities. More information is available at NationwideChildrens.org.
Enlighten Mobility Communications Contact: